{"id":"https://openalex.org/W2994949240","doi":"https://doi.org/10.1016/j.tips.2019.11.003","title":"Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy","display_name":"Preserving the CTLA-4 Checkpoint for Safer and More Effective Cancer Immunotherapy","alternate_titles":[],"publication_year":2019,"publication_date":"2019-12-10","ids":{"openalex":"https://openalex.org/W2994949240","doi":"https://doi.org/10.1016/j.tips.2019.11.003","mag":"2994949240","pmid":"https://pubmed.ncbi.nlm.nih.gov/31836191","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7210725"},"language":"en","primary_location":{"id":"doi:10.1016/j.tips.2019.11.003","doi":"https://doi.org/10.1016/j.tips.2019.11.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.tips.2019.11.003","pdf_url":null,"source":{"id":"https://openalex.org/S31167473","display_name":"Trends in Pharmacological Sciences","issn_l":"0165-6147","issn":["0165-6147","1873-3735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in Pharmacological Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2994949240"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC7210725","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100356037","display_name":"Yang Liu","orcid":"https://orcid.org/0000-0002-9442-700X","observed_orcids":["https://orcid.org/0000-0002-9442-700X"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]},{"id":"https://openalex.org/I4210149017","display_name":"OncoImmune (United States)","ror":"https://ror.org/04dj5bz65","country_code":"US","type":"company","lineage":["https://openalex.org/I4210149017"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Yang Liu","raw_affiliation_strings":["Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland, Baltimore, MD 21201, USA; OncoImmune, Inc., Rockville, MD 20850, USA. Electronic address: yaliu@ihv.umaryland.edu","Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland, Baltimore, MD 21201, USA","OncoImmune, Inc., Rockville, MD 20850, USA"],"raw_orcid":"https://orcid.org/0000-0002-9442-700X","affiliations":[{"raw_affiliation_string":"Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland, Baltimore, MD 21201, USA; OncoImmune, Inc., Rockville, MD 20850, USA. Electronic address: yaliu@ihv.umaryland.edu","institution_ids":["https://openalex.org/I126744593","https://openalex.org/I4210149017"]},{"raw_affiliation_string":"Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland, Baltimore, MD 21201, USA","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"OncoImmune, Inc., Rockville, MD 20850, USA","institution_ids":["https://openalex.org/I4210149017"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056309387","display_name":"Pan Zheng","orcid":"https://orcid.org/0000-0003-2598-3544","observed_orcids":["https://orcid.org/0000-0003-2598-3544"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]},{"id":"https://openalex.org/I4210149017","display_name":"OncoImmune (United States)","ror":"https://ror.org/04dj5bz65","country_code":"US","type":"company","lineage":["https://openalex.org/I4210149017"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Pan Zheng","raw_affiliation_strings":["Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland, Baltimore, MD 21201, USA; OncoImmune, Inc., Rockville, MD 20850, USA. Electronic address: pzheng@ihv.umaryland.edu","Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland, Baltimore, MD 21201, USA","OncoImmune, Inc., Rockville, MD 20850, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland, Baltimore, MD 21201, USA; OncoImmune, Inc., Rockville, MD 20850, USA. Electronic address: pzheng@ihv.umaryland.edu","institution_ids":["https://openalex.org/I126744593","https://openalex.org/I4210149017"]},{"raw_affiliation_string":"Division of Immunotherapy, Institute of Human Virology and Department of Surgery, University of Maryland, Baltimore, MD 21201, USA","institution_ids":["https://openalex.org/I126744593"]},{"raw_affiliation_string":"OncoImmune, Inc., Rockville, MD 20850, USA","institution_ids":["https://openalex.org/I4210149017"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5056309387","https://openalex.org/A5100356037"],"corresponding_institution_ids":["https://openalex.org/I126744593","https://openalex.org/I4210149017"],"apc_list":{"value":4000,"currency":"USD","value_usd":4000},"apc_paid":null,"fwci":1.3765,"has_fulltext":false,"cited_by_count":171,"citation_normalized_percentile":{"value":0.82080925,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"41","issue":"1","first_page":"4","last_page":"12"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ctla-4","display_name":"CTLA-4","score":0.9940000176429749},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9079999923706055},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8640000224113464},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.890999972820282},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.8569999933242798},{"id":"https://openalex.org/keywords/immune-related-adverse-events","display_name":"immune-related adverse events","score":0.9010000228881836},{"id":"https://openalex.org/keywords/anti-ctla-4-antibody","display_name":"anti-CTLA-4 antibody","score":0.8709999918937683},{"id":"https://openalex.org/keywords/immune-tolerance","display_name":"immune tolerance","score":0.43700000643730164},{"id":"https://openalex.org/keywords/treg-depletion","display_name":"Treg depletion","score":0.574999988079071}],"concepts":[{"id":"https://openalex.org/C2776654903","wikidata":"https://www.wikidata.org/wiki/Q2601463","display_name":"SAFER","level":2,"score":0.7120363116264343},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.6817360520362854},{"id":"https://openalex.org/C21705690","wikidata":"https://www.wikidata.org/wiki/Q2907609","display_name":"CTLA-4","level":4,"score":0.5582982897758484},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5572227835655212},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5517489910125732},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4948853850364685},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.33361685276031494},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.19637957215309143},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1961321234703064},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.13903582096099854},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.12345966696739197},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.09659501910209656}],"mesh":[{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000082082","descriptor_name":"Immune Checkpoint Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D060908","descriptor_name":"CTLA-4 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.tips.2019.11.003","doi":"https://doi.org/10.1016/j.tips.2019.11.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.tips.2019.11.003","pdf_url":null,"source":{"id":"https://openalex.org/S31167473","display_name":"Trends in Pharmacological Sciences","issn_l":"0165-6147","issn":["0165-6147","1873-3735"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in Pharmacological Sciences","raw_type":"journal-article"},{"id":"pmid:31836191","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31836191","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trends in pharmacological sciences","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:6685659","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC7210725","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:7210725","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7210725/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Trends Pharmacol Sci","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:6685659","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC7210725","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2481120389","display_name":"Checkpoints in the cellular response to tissue injury","funder_award_id":"R01AI064350","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G2539231230","display_name":"First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy","funder_award_id":"R44CA250824","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G8290967948","display_name":"A Mouse Model to Assess Long Term Immunotherapy-related Adverse Effects in Children","funder_award_id":"R01CA227671","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320308296","display_name":"Melanoma Research Alliance","ror":"https://ror.org/025ck6r46"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":68,"referenced_works":["https://openalex.org/W1486722793","https://openalex.org/W1487731794","https://openalex.org/W1498093713","https://openalex.org/W1574766328","https://openalex.org/W1575585006","https://openalex.org/W1968546256","https://openalex.org/W2002726823","https://openalex.org/W2002861511","https://openalex.org/W2004281734","https://openalex.org/W2012972418","https://openalex.org/W2015085911","https://openalex.org/W2032289653","https://openalex.org/W2041218370","https://openalex.org/W2045654426","https://openalex.org/W2045932062","https://openalex.org/W2048073154","https://openalex.org/W2055901890","https://openalex.org/W2059123794","https://openalex.org/W2060451389","https://openalex.org/W2061071534","https://openalex.org/W2076067786","https://openalex.org/W2081255498","https://openalex.org/W2087013294","https://openalex.org/W2087482409","https://openalex.org/W2090077005","https://openalex.org/W2092987197","https://openalex.org/W2094366129","https://openalex.org/W2094991897","https://openalex.org/W2097811455","https://openalex.org/W2097995306","https://openalex.org/W2100228832","https://openalex.org/W2101581360","https://openalex.org/W2112123471","https://openalex.org/W2121080857","https://openalex.org/W2128758225","https://openalex.org/W2133075384","https://openalex.org/W2136746908","https://openalex.org/W2138125422","https://openalex.org/W2143163879","https://openalex.org/W2146907765","https://openalex.org/W2152611311","https://openalex.org/W2156248833","https://openalex.org/W2162856391","https://openalex.org/W2166662937","https://openalex.org/W2166725781","https://openalex.org/W2516271598","https://openalex.org/W2572174216","https://openalex.org/W2584410020","https://openalex.org/W2737785069","https://openalex.org/W2752227448","https://openalex.org/W2753432434","https://openalex.org/W2790795290","https://openalex.org/W2792557198","https://openalex.org/W2792937256","https://openalex.org/W2793286287","https://openalex.org/W2797675588","https://openalex.org/W2883858361","https://openalex.org/W2887577080","https://openalex.org/W2888298425","https://openalex.org/W2894584497","https://openalex.org/W2894717949","https://openalex.org/W2894796660","https://openalex.org/W2903166095","https://openalex.org/W2955472368","https://openalex.org/W3043703771","https://openalex.org/W4235973183","https://openalex.org/W4245523947","https://openalex.org/W4253193856"],"related_works":["https://openalex.org/W4313368643","https://openalex.org/W3031189585","https://openalex.org/W4220969080","https://openalex.org/W3082748943","https://openalex.org/W3180633808","https://openalex.org/W2955472368","https://openalex.org/W2020727013","https://openalex.org/W7172218044","https://openalex.org/W3013016503","https://openalex.org/W3095315588"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2994949240","counts_by_year":[{"year":2026,"cited_by_count":20},{"year":2025,"cited_by_count":27},{"year":2024,"cited_by_count":40},{"year":2023,"cited_by_count":29},{"year":2022,"cited_by_count":26},{"year":2021,"cited_by_count":18},{"year":2020,"cited_by_count":11}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2019-12-26T00:00:00"}
